FACIT generates $1.5 billion in follow-on investment
A commercialization landmark for Ontario cancer innovations and patient impact
TORONTO, March 29, 2023 /CNW/ – FACIT announced $1.5 billion in follow-on investment attracted to its portfolio of cancer biotechnology start-ups in Ontario, a significant milestone for life science commercialization in Canada. FACIT partners with start-ups to commercialize their made-in-Ontario technologies and intellectual property (IP). With FACIT’s expertise and seed capital, Ontario companies have gone on to create skilled jobs and high-tech facilities while keeping homegrown talent from leaving the province.
“This financing milestone represents a major win for Ontario’s innovation economy, and an unprecedented return on research investment for taxpayers,” said Dr. David O’Neill, President of FACIT. “It also signals hope for the two-in-five Ontarians who will be diagnosed with cancer and could have their cancer prevented, detected or treated by one of these innovations.”
FACIT and its strategic research partner, the Ontario Institute for Cancer Research (OICR), were created to capitalize on Ontario’s world-renowned medical research hub. To achieve this bold commercialization strategy, FACIT created its Prospects Oncology and Compass Rose Oncology Funds to invest in Ontario entrepreneurs and seed a domestic industrial pathway to drive cancer clinical trials and economic development.
By leveraging early investment exits, FACIT has established its own source of risk-capital and demonstrated the value of capitalizing on Ontario life sciences IP. Following consecutive waves of commercialization success, FACIT has made approximately $60 million in private sector returns available for reinvestment into Ontario innovation and the next generation of biotech leaders, including CTRL Therapeutics, Fusion Pharmaceuticals, Radiant Biotherapeutics, Tenomix, Xpan and others.
Given the global health marketplace is worth $10 trillion, capturing even a 1% share from homegrown IP could be a major boon for the economy, for cancer research, and for the patients who benefit from new breakthroughs.
“Implementing the principles of seed venture investing in a public research setting establishes an Ontario First pathway for cancer innovation,” Dr. O’Neill added. “With over 30 times leverage from the private sector, this novel commercialization venture has created tremendous value from homegrown IP, advancing start-ups and accelerating clinical trials.”
“Congratulations to FACIT on the impressive growth of its portfolio companies and the success of its groundbreaking approach to commercialization. OICR’s unique partnership with FACIT continues to generate great outcomes in our joint mission to advance cancer research innovations led by OICR researchers and their key collaborators to improve outcomes for people with cancer and grow Ontario’s economy,” said Dr. Laszlo Radvanyi, President and Scientific Director of OICR.
“Our government is focused on the long-term economic growth of Ontario by supporting entrepreneurs and making key investments in research and innovation,” said Jill Dunlop, Minister of Colleges and Universities. “Ontario’s support for leading organizations like FACIT highlights our province’s commitment to maximizing the value of made-in-Ontario research and intellectual property, so we can increase commercialization opportunities and ultimately help our discoveries reach patients so they can lead longer and healthier lives.”
“Through our Life Sciences Strategy, we’re ensuring Ontario remains at the forefront of innovation and continues to be a global leader in life sciences,” said Vic Fedeli, Minister of Economic Development, Job Creation and Trade. “FACIT’s milestone is great news for the sector and an important step forward in Ontario cancer innovation. We’re committed to adopting innovative approaches to secure and grow our position as an attractive destination to do business.”
FACIT is an award-winning commercialization venture firm that builds companies with entrepreneurs to accelerate oncology innovation, with a portfolio that has attracted more than $1.5 billion in investment to Ontario. Blending industry experience, capital and the unsurpassed clinician-scientist network of its strategic partner the Ontario Institute for Cancer Research (OICR), FACIT capitalizes on the province’s investment in research and healthcare to the benefit of the local economy and patients worldwide. Cancer Breakthroughs. Realized. facit.ca.
View original content:https://www.prnewswire.com/news-releases/facit-generates-1-5-billion-in-follow-on-investment-301784531.html
HackCapital launches investment platform competitor to Odin and Vauban – TechCrunch
Much in the way that AngelList and CircleUp have helped U.S. startups with angel investing, HackCapital wants to do the same for Europe’s impact solution-focused startups.
Co-founders and industry angel investors, Arman Anatürk, Camille Bossel and Emilie Dellecker launched the Switzerland-based entity out of stealth Tuesday to join similar groups, like Vauban, Odin and Roundtable, in helping founders, fund managers and syndicates in the climate tech industry raise capital from their networks for their own raises.
HackCapital is the fundraising and financing arm of Hack Group, the creators of the food tech community FoodHack and HackSummit. It provides a way for startups, funds and syndicates to use the HackCapital platform to launch an investment vehicle and pool capital from multiple investors in their network into the funding round, said Anatürk, co-founder and CEO of HackCapital, via email.
HackCapital manages the legal and administrative services behind these pooling mechanisms via a fully digitized platform that makes issuing and investing easier and more affordable.
To date, over 30 funds and startups have used the infrastructure to roll up investors into their rounds, including Vienna-based Arkeon and Canada-based New School Foods, Anatürk said.
Where Anatürk said HackCapital is doing something different is that it is using a securitization structure, which centralizes the administration to bypass the needs of traditional special purchase vehicles, which limits the number of investors.
“HackCapital’s infrastructure is specifically designed for liquidity and secondaries,” Anatürk said. “We believe that the private markets will play a critical role in solving climate and health in the next decades, but the lack of liquidity is one of the main factors that prevents more capital flowing towards meaningful innovation and impact, especially in deep-tech fields, where the innovation cycles take longer than the typical 10 years fund return.”
Twitter may be worth one-third what Musk paid for it last fall as Fidelity marks down investment – ABC News
Twitter may now be worth one-third of what Elon Musk paid for the social media platform just seven months ago
Twitter may now be worth one-third of what Elon Musk paid for the social media platform just seven months ago.
Financial services company Fidelity has reduced the market value of its equity stake in Twitter for a third time, now putting it at $6.55 billion. That’s down from the nearly $20 billion Fidelity valued its stake at in October.
It is unclear how Fidelity came up with its valuation figures, but as a public company it’s required to provide investors with updates on its holdings. Because Twitter is a private company now called X Holdings Corp., information about its finances can’t be verified.
Musk took control of Twitter in October, after a protracted legal battle and months of uncertainty. The CEO of Tesla, who also owns SpaceX, bought Twitter for $44 billion.
The billionaire financed the purchase with funds including loans from a group of banks. Musk has said the $44 billion price tag for Twitter was too high but that the company had great potential.
By April Musk was telling the BBC that running Twitter has been “ quite painful ” but that the social media company is now roughly breaking even after he acquired it late last year. Musk predicted at the time that Twitter could become “cash flow positive” in the current quarter “if current trends continue.”
Paramount stock rises another 6% as investors cheer Loop Capital upgrade, new investment deal
Paramount Global (PARA) closed Tuesday’s trading session more than 6% higher after Loop Capital upgraded the stock late last week, suggesting financial pressures surrounding the company will force it to find a buyer.
Loop Capital upgraded shares to Hold from Sell but reiterated its price target of $14 a share with analyst Alan Gould telling investors, “We no longer believe the downside is that much greater than the upside.”
“While we still believe a turnaround of PARA will be a challenge, investors’ perception of the company could change with a motivated seller, clever bankers, and Berkshire’s purse strings,” he said.
“The bull case is that the financial pressure will force PARA to find a buyer and shareholders will achieve private market value. The bear case is that there are no buyers for the cable assets, the streaming business is a work-in-process, and Shari Redstone will not sell just the studio, the only asset that would have multiple highly interested buyers,” Gould added.
Shari Redstone currently serves as the non-executive chairwoman of Paramount Global, in addition to president of her family’s holding company, National Amusements (NAI), which controls the company through its class A shares.
Paramount closed Friday’s trading session up 6% after BDT Capital Partners, an affiliate of BDT & MSD Partners, funded a $125 million preferred equity investment in National Amusements.
The investment will help NAI pay down its revolving loan and recent term loan borrowings, according to a press release. Paramount has recently battled layoffs, business restructurings, and a dividend cut that sent the stock plummeting nearly 30%.
“Our expanded partnership with BDT & MSD reflects our strong belief in Paramount’s ability to deliver value to all shareholders,” Redstone said in the release.
“NAI has conviction in Paramount’s strategy and execution, and we remain committed to supporting Paramount as it takes the necessary steps to build on its success and capitalize on the strategic opportunities in our industry,” she continued.
Paramount has long been viewed as a potential acquisition target due to its small size relative to competitors. The company boasts a current market cap of about $10 billion, compared to Disney’s (DIS) $161 billion and Netflix’s (NFLX) $176 billion.
Paramount CEO Bob Bakish hinted more media M&A was on the horizon while speaking at a UBS media conference late last year.
“Consolidation has been the rule in business for a long time, certainly been the rule in media,” he said at the time. “So, it’s hard for me to bet on anything other than consolidation will happen in the future.”
In February, shortly following the announcement that Paramount would be folding Showtime into Paramount+, The Wall Street Journal revealed the company had turned down a more than $3 billion offer from executive David Nevins to buy Showtime.
Nevins’ proposal was one of many offers the company had received for Showtime over the past several years, the Journal said. The network, which is home to popular shows like “Billions” and “Yellowjackets,” was said to be a key driver in unlocking value for the media giant.
In addition to the Showtime offer, the company has tip-toed around recent reports of a potential sale of the company’s BET Media Group, which includes cable channels BET and VH1, after producer Tyler Perry and media mogul Byron Allen reportedly expressed interest in purchasing a majority stake.
Warren Buffett’s Berkshire Hathaway (BRK-B) boosted its stake in Paramount Global in the fourth quarter of 2022, purchasing an additional 2.4 million shares worth more than $40 million, according to a regulatory filing released on February 14, pushing its stake in the company north of 93 million shares.
Another Buffett connection lies in BDT & MSD Partners’ Chairman and Co-CEO Byron Trott — long known as a trusted advisor of Buffett.
“Paramount has an incredible legacy, underpinned by its industry-leading content and media assets. We believe strongly in the value creation opportunities ahead for the company and its shareholders,” Trott said in Friday’s release.
Still, not everyone is convinced a sale is on the horizon — at least not right away.
Wells Fargo analyst Steve Cahall suggested on Tuesday that Redstone’s “conviction” in Paramount’s strategy implies “a break up of the company is not likely anytime soon.”
Alexandra Canal is a Senior Reporter at Yahoo Finance. Follow her on Twitter @allie_canal, LinkedIn, and email her at firstname.lastname@example.org
COVID-19's 'long tail' analyzed at European rheumatology congress – The Science Board
Cigarettes in Canada will soon bear their own health warnings – CTV News
AI: War crimes evidence erased by social media platforms – BBC
Silver investment demand jumped 12% in 2019
Iran anticipates renewed protests amid social media shutdown
Search for life on Mars accelerates as new bodies of water found below planet’s surface
Tech22 hours ago
Montreal-Trudeau International Airport’s Runway 10-28 to be decommissioned and turned into taxiway
News22 hours ago
Pulp giant Paper Excellence’s secretive owner could face parliamentary summons
News22 hours ago
Analyzing Danielle Smith’s Alberta Election Win and its Implications for Black Albertans
Science22 hours ago
SpaceX Dragon capsule carrying private Ax-2 astronauts splashes down off Florida coast (video)
Sports22 hours ago
Treliving to be hired as Leafs general manager
Science21 hours ago
Webb telescope finds towering plume of water escaping from one of Saturn’s moons
Health23 hours ago
Low sexual satisfaction linked to future memory loss: study
Tech21 hours ago
TechScape: Will Apple’s new VR headset be the one to finally catch on?